Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Chun

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Investigational New Drugs|January 19, 2000
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319)A Mittelman, H G Chun, C Puccio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up reportJ M Sorensen, D A Vena, A Fallavollita, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
International Journal of Clinical & Laboratory Research|January 1, 1992
Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapyZ A Arlin, T Ahmed, A Mittelman, et al.
Investigational New Drugs|January 1, 1986
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agentH G Chun, B Davies, D Hoth, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 10, 1999
Evaluation of left ventricular diastolic function when mitral E and A waves are completely fused: role of assessing mitral annulus velocityD W Sohn, Y J Kim, H C Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Amsacrine retains a special role supporting Food and Drug Administration approvalZ A Arlin, E J Feldman, P Cook, et al.
Seminars in Hematology|July 1, 1991
"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatmentZ A Arlin, E J Feldman, L Finger, et al.
Journal of the National Cancer Institute|December 6, 1989
Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancerJ L Abbruzzese, A Weeks, M N Raber, et al.
Investigational New Drugs|January 1, 1987
Merbarone: an antitumor agent entering clinical trialsA Glover, H G Chun, L M Kleinman, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Investigational New Drugs|January 19, 2000
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319)A Mittelman, H G Chun, C Puccio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up reportJ M Sorensen, D A Vena, A Fallavollita, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
International Journal of Clinical & Laboratory Research|January 1, 1992
Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapyZ A Arlin, T Ahmed, A Mittelman, et al.
Investigational New Drugs|January 1, 1986
Didemnin B. The first marine compound entering clinical trials as an antineoplastic agentH G Chun, B Davies, D Hoth, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 10, 1999
Evaluation of left ventricular diastolic function when mitral E and A waves are completely fused: role of assessing mitral annulus velocityD W Sohn, Y J Kim, H C Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Amsacrine retains a special role supporting Food and Drug Administration approvalZ A Arlin, E J Feldman, P Cook, et al.
Seminars in Hematology|July 1, 1991
"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatmentZ A Arlin, E J Feldman, L Finger, et al.
Journal of the National Cancer Institute|December 6, 1989
Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancerJ L Abbruzzese, A Weeks, M N Raber, et al.
Investigational New Drugs|January 1, 1987
Merbarone: an antitumor agent entering clinical trialsA Glover, H G Chun, L M Kleinman, et al.
Pageof 3